Menta Capital’s Charles River Laboratories CRL Stock Holding History

Menta Capital’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,780	Closed	-$315K	–	514
2018 Q4	$315K	Sell	2,780 -8,039	-74%	-$1.01M	0.12%	292
2018 Q3	$1.46M	Buy	10,819 +8,294	+328%	+$1.02M	0.51%	24
2018 Q2	$283K	Buy	+2,525	New	+$273K	0.07%	495
2017 Q1	–	Sell	-18,336	Closed	-$1.4M	–	837
2016 Q4	$1.4M	Buy	+18,336	New	+$1.39M	0.12%	300
2016 Q1	–	Sell	-16,380	Closed	-$1.32M	–	918
2015 Q4	$1.32M	Sell	16,380 -9,200	-36%	-$664K	0.17%	176
2015 Q3	$1.63M	Buy	+25,580	New	+$1.84M	0.26%	105
2014 Q3	–	Sell	-10,800	Closed	-$578K	–	612
2014 Q2	$578K	Buy	+10,800	New	+$593K	0.11%	264
2013 Q3	–	Sell	-5,200	Closed	-$213K	–	372
2013 Q2	$213K	Buy	+5,200	New	+$223K	0.14%	308

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Menta Capital's CRL Position: Q1 2019 in Review

Menta Capital sold out of Charles River Laboratories (CRL) in Q1 2019, closing a stake of 2,780 shares — an estimated $315K sold.

Menta Capital first reported a position in CRL in Q2 2013 and held it in 8 quarters. The position peaked at $1.63M in Q3 2015. 409 funds tracked by Wall St. Rank hold CRL as of Q1 2019.

Menta Capital reported no remaining Charles River Laboratories position as of Q1 2019 after selling out during the quarter.
Menta Capital sold 2,780 Charles River Laboratories shares in Q1 2019, an estimated $315K.
Menta Capital first reported a position in Charles River Laboratories in Q2 2013 and held it in 8 quarters.
Menta Capital's Charles River Laboratories position peaked at $1.63M in Q3 2015.
409 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2019.

Based on Menta Capital's 13F filing for Q1 2019, filed 1 May 2019.